BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28637476)

  • 1. Eliminating acetate formation improves citramalate production by metabolically engineered Escherichia coli.
    Parimi NS; Durie IA; Wu X; Niyas AMM; Eiteman MA
    Microb Cell Fact; 2017 Jun; 16(1):114. PubMed ID: 28637476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of citramalic acid from glycerol by metabolically engineered Escherichia coli.
    Wu X; Eiteman MA
    J Ind Microbiol Biotechnol; 2017 Oct; 44(10):1483-1490. PubMed ID: 28744578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of citramalate by metabolically engineered Escherichia coli.
    Wu X; Eiteman MA
    Biotechnol Bioeng; 2016 Dec; 113(12):2670-2675. PubMed ID: 27316562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered citrate synthase improves citramalic acid generation in Escherichia coli.
    Wu X; Tovilla-Coutiño DB; Eiteman MA
    Biotechnol Bioeng; 2020 Sep; 117(9):2781-2790. PubMed ID: 32497258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient bio-production of citramalate using an engineered Escherichia coli strain.
    Webb JP; Arnold SA; Baxter S; Hall SJ; Eastham G; Stephens G
    Microbiology (Reading); 2018 Feb; 164(2):133-141. PubMed ID: 29231156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrate synthase variants improve yield of acetyl-CoA derived 3-hydroxybutyrate in Escherichia coli.
    Rajpurohit H; Eiteman MA
    Microb Cell Fact; 2024 Jun; 23(1):173. PubMed ID: 38867236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic engineering for efficient supply of acetyl-CoA from different carbon sources in Escherichia coli.
    Zhang S; Yang W; Chen H; Liu B; Lin B; Tao Y
    Microb Cell Fact; 2019 Aug; 18(1):130. PubMed ID: 31387584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliminating side products and increasing succinate yields in engineered strains of Escherichia coli C.
    Jantama K; Zhang X; Moore JC; Shanmugam KT; Svoronos SA; Ingram LO
    Biotechnol Bioeng; 2008 Dec; 101(5):881-93. PubMed ID: 18781696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of engineered Escherichia coli AF1000 and BL21 strains for (R)-3-hydroxybutyrate production in fed-batch cultivation.
    Perez-Zabaleta M; Guevara-Martínez M; Gustavsson M; Quillaguamán J; Larsson G; van Maris AJA
    Appl Microbiol Biotechnol; 2019 Jul; 103(14):5627-5639. PubMed ID: 31104101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate Production by Escherichia coli by Use of Pyruvate Dehydrogenase Variants.
    Moxley WC; Eiteman MA
    Appl Environ Microbiol; 2021 Jun; 87(13):e0048721. PubMed ID: 33863707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic engineering of Escherichia coli for the production of 1-propanol.
    Choi YJ; Park JH; Kim TY; Lee SY
    Metab Eng; 2012 Sep; 14(5):477-86. PubMed ID: 22871504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glycolytic flux improves pyruvate production by a metabolically engineered Escherichia coli strain.
    Zhu Y; Eiteman MA; Altman R; Altman E
    Appl Environ Microbiol; 2008 Nov; 74(21):6649-55. PubMed ID: 18806005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic engineering of Escherichia coli W3110 to produce L-malate.
    Dong X; Chen X; Qian Y; Wang Y; Wang L; Qiao W; Liu L
    Biotechnol Bioeng; 2017 Mar; 114(3):656-664. PubMed ID: 27668703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redistribution of metabolic fluxes in the central aerobic metabolic pathway of E. coli mutant strains with deletion of the ackA-pta and poxB pathways for the synthesis of isoamyl acetate.
    Dittrich CR; Vadali RV; Bennett GN; San KY
    Biotechnol Prog; 2005; 21(2):627-31. PubMed ID: 15801810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of poxB, pta, and ackA improves 1,3-propanediol production by Klebsiella pneumoniae.
    Lin J; Zhang Y; Xu D; Xiang G; Jia Z; Fu S; Gong H
    Appl Microbiol Biotechnol; 2016 Mar; 100(6):2775-84. PubMed ID: 26695159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergent Synthesis of Two Heterogeneous Fluxes from Glucose and Acetate for High-Yield Citramalate Production.
    Nam SH; Ye DY; Hwang HG; Jung GY
    J Agric Food Chem; 2024 Mar; 72(11):5797-5804. PubMed ID: 38465388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the acetate-producing pathways in Escherichia coli.
    Dittrich CR; Bennett GN; San KY
    Biotechnol Prog; 2005; 21(4):1062-7. PubMed ID: 16080684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of genetic manipulation strategies on D-lactate production by Escherichia coli.
    Zhou L; Zuo ZR; Chen XZ; Niu DD; Tian KM; Prior BA; Shen W; Shi GY; Singh S; Wang ZX
    Curr Microbiol; 2011 Mar; 62(3):981-9. PubMed ID: 21086129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered citrate synthase alters Acetate Accumulation in Escherichia coli.
    Tovilla-Coutiño DB; Momany C; Eiteman MA
    Metab Eng; 2020 Sep; 61():171-180. PubMed ID: 32569710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetate accumulation through alternative metabolic pathways in ackA (-) pta (-) poxB (-) triple mutant in E. coli B (BL21).
    Phue JN; Lee SJ; Kaufman JB; Negrete A; Shiloach J
    Biotechnol Lett; 2010 Dec; 32(12):1897-903. PubMed ID: 20703804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.